Itzik On

Investing in bold initiatives (preseed lead upto series C syndication)

📍 United States🔄 Updated September 2026💼 18 investments📅 10 years investing🗓 Last invested May 2024
VC🌍 United States
18
Total investments
10
Early stage
4
Mid stage
1
Late stage
10y
Years active

Portfolio

17 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
May 2024
Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body. In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks. Join us as we embark on the task to "turn back time."​
late stageBiotechnology
Seed Investor
Jan 2024
We are group of IP professionals, data scientists and software developers researching improvements in patent searching technology, better enabling corporations and inventors to capture and protect innovation.
Investor
Nov 2023
Cellular Intelligence is an AI-native TechBio company building the first universal virtual cell- signaling model to decode and control the complex language of cells. Using our proprietary capsule technology, we generate dynamic cellular data at over 1,000x higher efficiency than existing methods. We train large-scale predictive models on this data to design and optimize regenerative medicine protocols, predict drug responses, and model disease mechanisms. Cellular Intelligence is based in Boston and founded by leading AI entrepreneurs and world-class scientists, engineers, and operators. We are backed by over $62 million from investors like Khosla Ventures and the Chan Zuckerberg Initiative. Follow along as we accelerate breakthroughs across human health.
Investor
Oct 2023
Gravitics, Inc. designs and manufactures large space structures, including orbital carriers, cargo logistics spacecraft, and space station modules. Gravitics is redefining space superiority and enabling a new era for commercial development in earth orbit and beyond. Visit gravitics.com to learn more.
Investor
Sep 2023
Unleashing AI-powered imaging for everything and everyone. Orbem combines rapid magnetic resonance imaging with advanced deep learning to shed light on the worlds toughest challenges. We are developing fast, accurate, and accessible imaging solutions that reveal hidden sources of knowledge. In everything we do, we seek to make a difference – and are leveraging deep tech solutions to sustainably feed the world, accelerate the transition to a green economy, and transform disease detection. Based on years of scientific research at the interface of AI and imaging technology, Orbem was founded in 2019 as a spin-off from the Technical University of Munich. Headquartered in Munich, our top tier, international, diverse, and multidisciplinary team is imagining new frontiers every single day to build a sustainable and healthy future. Discover our first line product, the Genus, at https://www.orbem.ai Join our team anywhere in the world and shape the future of AI-powered imaging.
Seed Investor
Jul 2023
Overview Voia is a technology company pioneering the future of virtual production. Our proprietary AI pipeline brings real actors into generative 3D environments — eliminating the need for green screens, LED stages, or complex post-production workflows. Designed for high-end productions, Voia’s system captures camera tracking, lighting, motion, and depth directly on set, enabling real-time previews and delivering same-day post-ready exports. Our tech stack includes: • On-Set Server: real-time tracking & previews • Voia Cloud: AI-powered compositing, relighting & automation • Web App: collaboration, workflow control & asset delivery Voia is trusted by global brands and creators to deliver visual quality, production speed, and creative freedom. Virtual Production, Powered by Intelligence.
Seed Investor
Jan 2023
Redflag is the AI-powered platform trusted by content owners to safeguard their work - whether it’s live, on-demand, or anywhere in between. We first set the standard for protecting static digital assets (from films and music to books, podcasts, and creator content) using ML based detection and monitoring techniques to remove piracy across social platforms, file lockers, and the open web. Now, with the launch of Cyclops, we offer the most advanced solution for live content protection, built to stop unauthorized streams in real time. Cyclops tracks piracy across IPTV, social video, and streaming platforms as it happens, giving rights holders the power to respond in minutes, not hours. With Redflag, content owners of all kinds can: Monitor and protect both live and static content 24/7 Detect unauthorized use with precision and speed Enforce globally and turn enforcement data into strategic value Your content. Your rules. Redflag enforces them.
Investor
Jan 2023
Simerse is leading the AI revolution for energy & infrastructure. Get in touch with us today!
Seed Investor
Sep 2022
Sevoyer is the first-ever crypto financial solution that sets its goal to serve our community in the first place. We aim to provide easy, fast & accessible crypto services worldwide.
Seed Investor
Aug 2022
DogBase is redefining working dogs interactions and training through artificial intelligence. We Believe in the Power of Tech to Elevate Working Dog Performance DogBase is centered on a shared belief in technology to systematically drive high-performance working dogs. Our platform is centered on frictionless logging, tracking, and making AI-driven improvements. DogBase is Techstars 2023 portfolio company
Investor
May 2022
Founded in 2019, Fetcherr is at the forefront of AI-driven solutions for the airline industry. Specializing in dynamic pricing and market forecasting, Fetcherr’s core product, the Generative Pricing Engine (GPE), leverages the Large Market Model (LMM) to optimize revenue and operational efficiency. The LMM simulates market dynamics, allowing the GPE to adjust and react in real-time to each part of the operational pipeline, from pricing to inventory management. Partnered with industry giants like Delta Airlines, Virgin Atlantic, WestJet, Azul and Viva Aerobus, Fetcherr’s technology empowers airlines to make real-time, data-driven decisions, ensuring a competitive edge and sustainable growth. Fetcherr’s AI-driven approach has demonstrated significant revenue generation uplift, transforming traditional revenue management processes and enhancing overall airline profitability.
Investor
Jun 2021
Impro.AI provides data-driven insights and tools that every executive needs to understand and optimize their companys management behavior. We help organizations, leaders and individuals to manage from clarity. By combining the best capabilities of AI and human mentorship, we offer a strategic solution that is systemic across coaching, mentoring, training and consulting. We help all employees, and their company as a whole, to realize new insights and improve performance, every day.
Investor
2019
Giddy is a sexual health company dedicated to helping individuals and their partners live more fulfilling lives through thought-leading educational content. Giddy uses insights learned from its dialogue with users to develop innovative medical devices. Giddys flagship product is called “Eddie by Giddy” - an FDA Class II medical device designed to treat ED and improve male sexual performance.
early stagePublic Health
Investor
2017
At Track160, we believe that every football coach and player deserves to have access to the same high-quality data solutions currently available only to the few elite clubs. That is why we developed a fully automated FIFA EPTS certified football data analytics platform designed for clubs, leagues, schools, and academies at any level. Using optical tracking technology that automatically identifies the location of multiple joints in a players body and tracks 3D pose and motion, we provide players and coaches with highly accurate data, video, and events in one product suite. The all-in-one solution leverages Computer Vision and proprietary Deep Learning techniques and therefore requires no initial expertise or complex installation. Track160 - elite standard data analytics in a simple to use, affordable solution for all levels of the game.
early stageSpectator Sports
Show all 17 investments ↓
Experience · 19 entries
All (19)
Investments (18)
2024
Investor
May 2024
Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body. In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks. Join us as we embark on the task to "turn back time."​
late stageBiotechnology
Investor
Feb 2024
HelixNano is building the worlds most advanced mRNA platform to enable previously impossible applications across human and non-human biology
Seed Investor
Jan 2024
We are group of IP professionals, data scientists and software developers researching improvements in patent searching technology, better enabling corporations and inventors to capture and protect innovation.
2023
Investor
Nov 2023
Cellular Intelligence is an AI-native TechBio company building the first universal virtual cell- signaling model to decode and control the complex language of cells. Using our proprietary capsule technology, we generate dynamic cellular data at over 1,000x higher efficiency than existing methods. We train large-scale predictive models on this data to design and optimize regenerative medicine protocols, predict drug responses, and model disease mechanisms. Cellular Intelligence is based in Boston and founded by leading AI entrepreneurs and world-class scientists, engineers, and operators. We are backed by over $62 million from investors like Khosla Ventures and the Chan Zuckerberg Initiative. Follow along as we accelerate breakthroughs across human health.
Show all 19 entries ↓
Investment activity
2016–2024 · 18 investments
20162201712019120211202232023620244
Recent (last 2 years)Earlier